Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3978278 | Brachytherapy | 2006 | 14 Pages |
Abstract
EBR alone is more effective than HDREB for symptom palliation in previously untreated patients with endobronchial non-small-cell lung cancer. HDREB with EBR seems to provide better symptom relief than EBR alone. HDREB is recommended for symptomatic patients with recurrent endobronchial obstruction previously treated by EBR, providing it is technically feasible.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Yee C. Ung, Edward Yu, Conrad Falkson, Adam E. Haynes, Denise Stys-Norman, William K. Evans,